Interaction of natriuretic peptide levels and ejection fraction on outcomes with dapagliflozin and empagliflozin in heart failure-Reference-Cited by-同舟云学术

Interaction of natriuretic peptide levels and ejection fraction on outcomes with dapagliflozin and empagliflozin in heart failure

Published:2023-05 Issue:5 Volume:25 Page:767-769
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European J of Heart Fail

Author:

Butler Javed¹²,Siddiqi Tariq Jamal²,Zannad Faiez³,Ferreira João Pedro³⁴,Fillipatos Gerasimos⁵,Anker Stefan D.⁶,Packer Milton⁷⁸

Affiliation:

1. Baylor Scott and White Research Institute Dallas TX USA

2. Department of Medicine University of Mississippi School of Medicine Jackson MS USA

3. Université de Lorraine, Inserm, Centre d'Investigations Cliniques‐Plurithématique 14‐33, and Inserm U1116, CHRU, F‐CRIN INI‐CRCT (Cardiovascular and Renal Clinical Trialists) Nancy France

4. Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine, University of Porto Porto Portugal

5. National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon Athens Greece

6. Department of Cardiology (CVK), Berlin Institute of Health Center for Regenerative Therapies (BCRT) German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin Berlin Berlin Germany

7. Baylor University Medical Center Dallas TX USA

8. Imperial College London UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ejhf.2854

Reference6 articles.

1. SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials

2. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

3. Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER ‐like endpoint definitions

4. N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes

5. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost‐effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA‐HF and DELIVER data;European Journal of Heart Failure;2024-03